×
About 5,855 results

ALLMedicine™ Autoimmune Hepatitis Center

Research & Reviews  2,843 results

Autoimmune hepatitis in practice, from diagnosis to complications: What is the role of ...
https://doi.org/10.1016/j.clinimag.2020.12.032
Clinical Imaging; Gomes NBN, Torres US et. al.

Jan 11th, 2021 - Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease of unknown origin that can lead to liver cirrhosis, hepatocellular carcinoma (HCC), liver transplantation or death. The diagnosis is performed upon a multifactorial score. Treatmen...

Infliximab Drug-Induced Autoimmune Hepatitis in a Patient With Crohn's Ileocolitis.
https://doi.org/10.1097/MJT.0000000000001230
American Journal of Therapeutics; Karanfilian B, Mahpour N et. al.

Jan 8th, 2021 - Infliximab Drug-Induced Autoimmune Hepatitis in a Patient With Crohn's Ileocolitis.|2021|Karanfilian B,Mahpour N,Sarkar A,|

Limitation of the simplified scoring system for the diagnosis of autoimmune Hepatitis w...
https://doi.org/10.1111/liv.14778
Liver International : Official Journal of the International Association for the Study of the Liver REFERENCES; Muratori P, Granito A et. al.

Jan 3rd, 2021 - Autoimmune Hepatitis (AIH) is a chronic inflammatory liver disease of unknown aetiology characterized by the presence of autoantibodies, hypergammaglobulinaemia with specific IgG increase and interface hepatitis on liver histology. The clinical co...

Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune...
https://doi.org/10.1016/j.jaut.2020.102591
Journal of Autoimmunity; Buitrago-Molina LE, Pietrek J et. al.

Jan 2nd, 2021 - Autoimmune hepatitis (AIH) is a chronic autoimmune inflammatory disease that usually requires life-long immunosuppression. Frequent relapses after discontinuation of therapy indicate that intrahepatic immune regulation is not restored by current t...

Case of autoimmune hepatitis with overlap systemic lupus erythematosus.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778742
BMJ Case Reports; Goyes D, Malladi VR et. al.

Dec 30th, 2020 - Autoimmune hepatitis (AIH) is an autoimmune liver disease characterised by the presence of autoantibodies including antinuclear antibodies, anti-smooth muscle antibody and hypergammaglobulinaemia. Systemic lupus erythematosus (SLE) is a systemic d...

see more →

Guidelines  5 results

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries
https://journals.lww.com/ajg/pages/articleviewer.aspx?year=2017&issue=01000&article=00013&type=Fulltext
The American Journal of Gastroenterology; Kwo,P.,et al

Jun 30th, 2017 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...

EASL Clinical Practice Guidelines: Autoimmune hepatitis.
https://doi.org/10.1016/j.jhep.2015.06.030
Journal of Hepatology;

Sep 5th, 2015 - EASL Clinical Practice Guidelines: Autoimmune hepatitis.|2015| ,|therapeutic use,standards,drug therapy,

British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepat...
https://doi.org/10.1136/gut.2010.235259
Gut Gleeson D, Heneghan MA et. al.

Jul 15th, 2011 - Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease which, if untreated, often leads to cirrhosis, liver failure and death. Major advances were made in its management based on controlled trials performed in England and the USA in th...

Diagnosis and Management of Autoimmune Hepatitis
https://www.aasld.org/sites/default/files/guideline_documents/autoimmunehepatitis2010.pdf
Michael P. Manns

May 31st, 2010 - Autoimmune hepatitis (AIH) is a generally unresolving inflammation of the liver of unknown cause. A working model for its pathogenesis postulates that environmental triggers, a failure of immune tolerance mechanisms, and a genetic predisposition c.

Diagnosis and management of autoimmune hepatitis.
https://doi.org/10.1002/hep.23584
Hepatology (Baltimore, Md.); Manns MP, Czaja AJ et. al.

May 31st, 2010 - Diagnosis and management of autoimmune hepatitis.|2010|Manns MP,Czaja AJ,Gorham JD,Krawitt EL,Mieli-Vergani G,|blood,diagnosis,drug therapy,immunology,pathology,

see more →

Clinicaltrials.gov  2,915 results

Autoimmune hepatitis in practice, from diagnosis to complications: What is the role of ...
https://doi.org/10.1016/j.clinimag.2020.12.032
Clinical Imaging; Gomes NBN, Torres US et. al.

Jan 11th, 2021 - Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease of unknown origin that can lead to liver cirrhosis, hepatocellular carcinoma (HCC), liver transplantation or death. The diagnosis is performed upon a multifactorial score. Treatmen...

Infliximab Drug-Induced Autoimmune Hepatitis in a Patient With Crohn's Ileocolitis.
https://doi.org/10.1097/MJT.0000000000001230
American Journal of Therapeutics; Karanfilian B, Mahpour N et. al.

Jan 8th, 2021 - Infliximab Drug-Induced Autoimmune Hepatitis in a Patient With Crohn's Ileocolitis.|2021|Karanfilian B,Mahpour N,Sarkar A,|

Limitation of the simplified scoring system for the diagnosis of autoimmune Hepatitis w...
https://doi.org/10.1111/liv.14778
Liver International : Official Journal of the International Association for the Study of the Liver REFERENCES; Muratori P, Granito A et. al.

Jan 3rd, 2021 - Autoimmune Hepatitis (AIH) is a chronic inflammatory liver disease of unknown aetiology characterized by the presence of autoantibodies, hypergammaglobulinaemia with specific IgG increase and interface hepatitis on liver histology. The clinical co...

Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune...
https://doi.org/10.1016/j.jaut.2020.102591
Journal of Autoimmunity; Buitrago-Molina LE, Pietrek J et. al.

Jan 2nd, 2021 - Autoimmune hepatitis (AIH) is a chronic autoimmune inflammatory disease that usually requires life-long immunosuppression. Frequent relapses after discontinuation of therapy indicate that intrahepatic immune regulation is not restored by current t...

Case of autoimmune hepatitis with overlap systemic lupus erythematosus.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778742
BMJ Case Reports; Goyes D, Malladi VR et. al.

Dec 30th, 2020 - Autoimmune hepatitis (AIH) is an autoimmune liver disease characterised by the presence of autoantibodies including antinuclear antibodies, anti-smooth muscle antibody and hypergammaglobulinaemia. Systemic lupus erythematosus (SLE) is a systemic d...

see more →

News  83 results

Treating Liver Disease During COVID-19: New Recommendations
https://www.medscape.com/viewarticle/930411

May 13th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary care providers, and, of course, their patien...

AASLD: Liver transplants should proceed despite COVID-19
https://www.mdedge.com/gihepnews/article/220026/coronavirus-updates/aasld-liver-transplants-should-proceed-despite-covid-19?channel=63993
M. Alexander Otto, MDedge News

Apr 1st, 2020 - In liver transplant recipients or patients with autoimmune hepatitis on immunosuppressive therapy, acute cellular rejection or disease flare should not be presumed in the face of active coronavirus disease 2019 (COVID-19), according to the America.

CymaBay Therapeutics scraps two studies of liver drug; shares plunge
https://www.reuters.com/article/us-cymabay-nash/cymabay-therapeutics-scraps-two-studies-of-liver-drug-shares-plunge-idUSKBN1XZ1MC

Nov 25th, 2019 - (Reuters) - CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after biopsies found a type of liver damage in some patients, sending its shares down over 75%. The drug developer said it had obs...

Study links hepatitis, higher mortality post liver transplant
https://www.mdedge.com/jcomjournal/article/211752/hepatology/study-links-hepatitis-higher-mortality-post-liver-transplant?channel=302
Richard Mark Kirkner

Nov 6th, 2019 - Liver transplant for the three predominant autoimmune liver diseases – primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis – has been known to have favorable outcomes overall, but little evidence comparing cholang.

Drug-Induced Liver Injury Clinical Practice Guidelines (2019)
https://reference.medscape.com/viewarticle/912596

May 5th, 2019 - Guidelines for drug-induced liver injury were published in March 2019 by the European Association for the Study of the Liver.[1] Diagnosis Classify drug-induced liver injury (DILI) as hepatocellular, cholestatic, or mixed according to the pattern ...

see more →

Patient Education  9 results see all →